Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Magnesium Sulfate Versus Ipratropuim Bromide in Acute Exacerbation of Chronic Obstructive Pulmonary Disease

NCT01136421 is registered in ClinicalTrials.gov with University of Monastir as lead sponsor.

NCT NCT01136421
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01136421 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Magnesium Sulfate Versus Ipratropuim Bromide in Acute Exacerbation of Chronic Obstructive Pulmonary Disease
Lead sponsor
University of Monastir
Phase
Phase 3
Overall status
Completed
Start date
January 31, 2005
Completion date
June 30, 2007
Enrollment
124 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

copd exacerbation